Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
A MS-lesion pattern discrimination plot based on geostatistics.
Do not judge a cell by its cover-diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
Early-onset of multiple sclerosis in a 5-year-old girl.
A case of multiple sclerosis and celiac disease.
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
A new model of cuprizone-mediated demyelination/remyelination.
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Varicella-zoster virus encephalomyelitis with a prominent demyelinating component.
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity.
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.
The role of chromogranin B in an animal model of multiple sclerosis.
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia.
Th17 cells in central nervous system autoimmunity.
Interferon Beta and Long-term Disability in Multiple Sclerosis.
Exploring myelin dysfunction in multiple system atrophy.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Pages
« first
‹ previous
…
451
452
453
454
455
456
457
458
459
…
next ›
last »